Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$806,167
+$228,467 QoQ
Shares Held
5,144
+36.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#694
of 1,603 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $88,098,662 across 9 Drug Manufacturers - General names. NVS ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,814 | $65,745,561 | |
| 2 | NVO |
Novo Nordisk A S
|
247,912 | $11,884,901 | |
| 3 | ABBV |
AbbVie Inc.
|
19,460 | $4,896,914 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,894 | $2,813,379 | |
| 5 | JNJ |
Johnson & Johnson
|
3,240 | $822,862 | |
| 6 | NVS |
Novartis AG
This page
|
5,144 | $806,167 | |
| 7 | PFE |
Pfizer Inc
|
19,204 | $462,432 | |
| 8 | AMGN |
Amgen Inc
|
960 | $347,635 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $806,167 | 5,144 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $577,700 | 3,782 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $250,509 | 1,817 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $233,012 | 1,817 | Shares | Sole | 2025-11-03 | |
| 2020-09-30 | $1,256,485 | 14,449 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,311,322 | 15,014 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $278,928 | 3,383 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||